Emerald Oil Inc (EOX) Drops 12.46% on January 12

Equities Staff |

Emerald Oil Inc (EOX) was one of the Russell 2000's biggest losers for Tuesday January 12 as the stock slid 12.46% to $0.83, a loss of $-0.1184 per share. Starting at an opening price of $0.90 a share, the stock traded between $0.80 and $0.96 over the course of the trading day. Volume was 183,688 shares over 370 trades, against an average daily volume of 343,386 shares and a total float of 8.71 million.

The losses send Emerald Oil Inc down to a market cap of $7.24 million. In the last year, Emerald Oil Inc has traded between $26.00 and $0.80, and its 50-day SMA is currently $1.49 and 200-day SMA is $4.60.

Emerald Oil Inc is an independent exploration and production company. The Company is engaged in acquiring acreage and developing oil and natural gas wells in the Williston Basin of North Dakota and Montana.

Emerald Oil Inc is based out of Denver, CO and has some 42 employees. Its CEO is McAndrew Rudisill.

For a complete fundamental analysis analysis of Emerald Oil Inc, check out Equities.com’s Stock Valuation Analysis report for EOX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…